Accuracy of weight and height estimation in an intensive care unit: Implications for clinical practice and research

Critical Care Medicine

Volumn 34, Issue 8, 2006, Pages 2153-2157

  Bloomfield, Roxanna ^a   Steel, Elizabeth ^a   MacLennan, Graeme ^b   Noble, David W ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Clinical trials; Critical care; Height; Visual estimation; Weight

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL STAFF; NURSING STAFF; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEACHING HOSPITAL; MIDDLE AGED; OBSERVER VARIATION;

ADULT; AGED; BODY HEIGHT; BODY WEIGHT; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; NURSING STAFF, HOSPITAL; OBSERVER VARIATION; PROSPECTIVE STUDIES;

EID: 33748098683     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000229145.04482.93     Document Type: Article

References (41)

1. Leary TS, Milner QJW, Niblett DJ: The accuracy of the estimation of body weight and height in the intensive care unit. Eur J Anaesthesiol 2000; 17:698-703
2. Tremblay A, Bandi V: Impact of body mass index on outcomes following critical care. Chest 2003; 123:1202-1207
3. Schultz MJ, Wolthuis EK: Excess body weight in critically ill patients. Ann Intern Med 2004; 141:485
4. Morgan DJ, Bray KM: Lean body mass as a predictor of drug dosage: Implications for drug therapy. Clin Pharmacokinet 1994; 26:292-307
5. Jolliet P, Pichard C, Biolo R, et al: Enteral nutrition in intensive care patients: A practical approach. Intensive Care Med 1998; 24:848-859
6. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
7. Simpson F, Doig GS: Parenteral vs. enteral nutrition in the critically ill patient: A meta-analysis of trials using the intention to treat principle. Intensive Care Med 2005; 31:12-23
8. Vincent JL, Moreno R, Takala J, et al: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
9. Carney DE, Meguid MM: Current concepts in nutritional assessment. Arch Surg 2002; 137:42-44
10. Erstad BL: Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med 2004; 30:18-32
11. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002; 166:1510-1514
12. Gibson S, Numa A: The importance of metabolic rate and the folly of body surface area calculations. Anaesthesia 2003; 58:50-55
13. Hollenberg SM, Ahrens TS, Annane D, et al: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-1948
14. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555
15. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis or septic shock. N Engl J Med 2001; 345:1368-1377
16. Coe TR, Halkes M, Houghton K, et al: The accuracy of visual estimation of weight and height in pre-operative supine patients. Anaesthesia 1999; 54:582-588
17. Schultz MJ, Wolthuis EK, Determann RM: Mixing up old data. Crit Care Med 2005; 33:1676
18. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
19. Brower RG, Matthay M, Schoenfeld D: Meta-analysis of acute lung injury and acute respiratory distress trials. Am J Respir Crit Care Med 2002; 166:1515-1517
20. O'Brien JM, Welsh CH: Excess body weight in critically ill patients. Ann Intern Med 2004; 141:485-486
21. Lyseng-Williamson KA, Perry CM: Drotrecogin alfa (activated). Drugs 2002; 62:617-630
22. Fourrier F: Recombinant human activated protein C in the treatment of severe sepsis: An evidence-based review. Crit Care Med 2004; 32:S534-S541
23. Levy H, Small D, Heiselman DE, et al: Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis. Ann Pharmacother 2005; 39:262-267
24. Tobin MJ: Principles and Practice of Intensive Care Monitoring. New York, McGraw-Hill, 1998
25. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, Wiley-Interscience, 1986
26. Hollenberg SM, Kavinsky CJ, Parillo JE: Cardiogenic shock. Ann Intern Med 1999; 131:47-59
27. Sandham JD, Russell DH, Brant RF, et al: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14
28. Palazzo M: Circulating volume and the clinical assessment of the circulation. Br J Anaesth 2001; 86:744-746
29. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. 3rd Edition. New York, Springer, 1998
30. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
31. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group: Lowdose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Lancet 2000; 356:2139-2143
32. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
33. Ferguson ND, Frutos-Vivar F, Esteban A, et al: Airway pressures, tidal volumes and mortality in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:21-30
34. Ferguson ND, Frutos-Vivar F, Esteban A: Tidal volumes and the acute respiratory distress syndrome. Crit Care Med 2005; 33:1473
35. Lipsey MW: Design sensitivity: Statistical power for experimental research. London, Sage Publications, 1990
36. Shadish WR, Cook TD, Campbell DT: Experimental and Quasi-Experimental Designs for Generalized Causal Inference. New York, Houghton Mifflin, 2002
37. Nasraway SA: Sepsis research: We must change course. Crit Care Med 1999; 27:427-430
38. Hebert PC, Cook DJ, Wells G, et al: The design of randomized clinical trials in critically ill patients. Chest 2002; 121:1290-1300
39. Carson SS, Shorr AF: Is implementation of research findings in the critically ill hampered by the lack of universal definitions of illness? Curr Opin Crit Care 2003; 9:308-315
40. Riou B, Landais P, Benoit V, et al: Distribution of probability of survival is a strategic issue for randomized trials in critically ill patients. Anesthesiology 2001; 95:56-63
41. Macias WL, Vallet B, Bernard GR, et al: Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis. Crit Care Med 2004; 32:2385-2391